# FDA Inspection 1013080 - Trinity Hospital - May 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/trinity-hospital/f364742a-2a4a-45de-a9fa-391fcb783ec9
Source feed: FDA_Inspections

> FDA Inspection 1013080 for Trinity Hospital on May 22, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013080
- Company Name: Trinity Hospital
- Inspection Date: 2017-05-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258496 - 2024-12-10](https://www.keypedia.com/records/fda_inspections/trinity-hospital/8c73e6b4-db2b-497d-aa59-1afdb8fbfe08)
- [FDA Inspection 1258496 - 2024-12-10](https://www.keypedia.com/records/fda_inspections/trinity-hospital/63105e49-2a35-4483-bdd8-350bb6f4736a)
- [FDA Inspection 1094258 - 2019-06-03](https://www.keypedia.com/records/fda_inspections/trinity-hospital/231757a5-1f38-4e4c-b023-f3c9663bead2)
- [FDA Inspection 923704 - 2015-04-08](https://www.keypedia.com/records/fda_inspections/trinity-hospital/38ef1ed8-f531-4c04-89fa-19e050e074fd)

Company: https://www.keypedia.com/companies/trinity-hospital/9d49cad8-875b-4b44-8ea5-d99f123a6fcc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d